Experiment 437755
Compounds isolated
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Administration route | INTRALESIONAL |
| Organism | Empty organism |
| Citation | BOUDREAUX,AA: SMITH,LL: COSBY,CD: BASON,MM: TAPPERO,JW: BERGER,TG:. (1993). INTRALESIONAL VINBLASTINE FOR CUTANEOUS KAPOSI'S SARCOMA ASSOCIATED WITH ACQUIRED IMMUNODEFICIENCY SYNDROME. A CLINICAL TRIAL TO EVALUATE EFFICACY AND DISCOMFORT ASSOCIATED WITH INJECTION.. 28(1) |
| Amount utilized | |
| Compound isolated | |
| Disease | ELEVEN PATIENTS WITH BIOPSY PROVEN KAPOSI SARCOMA WERE TREATED IN THIS STUDY. PATIENTS WERE TREATED WITH BICARBONATE BUFFERED LIDOCAINE OR COMBINED WITH VINCALEUKOBLASTINE OR WITH VINCALEUKOBLASTINE ALONE. THERE WAS A COMPLETE OR PARTIAL RESPONSE IN 88% OF THE VINCALEUKOBLASTINE-TREATED LESIONS. PAIN SCORES BETWEEN THE 2 TREATED GROUPS WERE NOT SIGNIFICANTLY DIFFERENT. |
| Dose amount | 0.5 MG |
| Number | 1 |
| Qualitative result | ACTIVE |
| Animal | HUMAN ADULT |
| Per unit | ML |
| Dose expression | DOSE |